In vivo efficiency of the produced recombinant lysostaphin antimicrobial peptide in treatment of methicillin-resistant Staphylococcus aureus (MRSA) skin infection in a mouse model

BACKGROUND AND OBJECTIVES: Staphylococcus simulans secretes an antimicrobial compound called lysostaphin, which has bactericidal properties. It destroys staphylococci through the hydrolysis of peptidoglycan in the cell wall. Therefore, this unique property indicates the high ability of lysostaphin i...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadoogh Abbasian, Shabnam, Ghaznavi-Rad, Ehsanollah, Sadelaji, Samira, Abtahi, Hamid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183077/
https://www.ncbi.nlm.nih.gov/pubmed/37193239
http://dx.doi.org/10.18502/ijm.v15i2.12476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183077/
https://www.ncbi.nlm.nih.gov/pubmed/37193239
http://dx.doi.org/10.18502/ijm.v15i2.12476

Ejemplares similares